ARTICLE | Company News
SPA, YM Biosciences cancer deal
January 31, 2001 8:00 AM UTC
Vaccine company SR Pharma (LSE:SPA) and YM Biosciences (Mississauga, Ontario), formerly York Medical, will investigate the use of SPA's SRL172 as a cancer adjuvant in combination with YM's IPS-21 canc...